US4158050A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for effecting female sterilization without surgery
Assignee: Family Health International 360
•
Filing: 1978-06-15
•
Granted: 1979-06-12
•
Expires: 1998-06-15
Abstract
Abstract The safety and effectiveness of the nonsurgical, female sterilization method involving the inducement of tubal occlusion by the transcervical application of quinacrine hydrochloride is greatly improved when the occluding agent is delivered in the form of a solid pellet.
Inventors
- 👤 Jaime Zipper
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 17:01
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0034; A61K9/0039
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
76 words
In a nonsurgical method for female sterilization wherein a liquid suspension of quinacrine hydrochloride is introduced into the uterine cavity in one or more treatments to effect an occlusion of the utero-tubal junction, the improvement which comprises applying said quinacrine hydrochloride in the form of a solid pellet having the configuration of a cylinder with rounded heads, a diameter of less than 4 millimeters and containing about 10 mg. of quinacrine hydrochloride per millimeter of length.
Claim 2
Dependent Claim
76 words
In a nonsurgical method for female sterilization wherein a liquid suspension of quinacrine hydrochloride is introduced into the uterine cavity in one or more treatments to effect an occlusion of the utero-tubal junction, the improvement which comprises applying said quinacrine hydrochloride in the form of a solid pellet having the configuration of a cylinder with rounded heads, a diameter of less than 4 millimeters and containing about 10 mg. of quinacrine hydrochloride per millimeter of length.
Claim 3
Dependent Claim
24 words
The improved method of claim 1 wherein said solid pellet contains 250 mg. of quinacrine hydrochloride and two pellets are administered with each treatment.
Claim 4
Dependent Claim
87 words
In a nonsurgical method for female sterilization wherein a liquid suspension of quinacrine hydrochloride is introduced into the uterine cavity in one or more treatments to effect an occlusion of the utero-tubal junction, the improvement which comprises applying said quinacrine hydrochloride in combination with sodium thiopental with both of said compounds being in the form of a solid pellet having the configuration of a cylinder with rounded heads, a diameter of less than 4 millimeters and containing about 10 mg. of quinacrine hydrochloride per millimeter of length.
Claim 5
Dependent Claim
87 words
In a nonsurgical method for female sterilization wherein a liquid suspension of quinacrine hydrochloride is introduced into the uterine cavity in one or more treatments to effect an occlusion of the utero-tubal junction, the improvement which comprises applying said quinacrine hydrochloride in combination with sodium thiopental with both of said compounds being in the form of a solid pellet having the configuration of a cylinder with rounded heads, a diameter of less than 4 millimeters and containing about 10 mg. of quinacrine hydrochloride per millimeter of length.
Claim 6
Dependent Claim
41 words
The improved method according to claim 3 wherein said quinacrine hydrochloride is applied at a dosage level of 500 mg. in each treatment and said sodium thiopental is applied at a dosage in the range of from 15 to 25 mg.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1982-06-11 | 1982-12-11 | 1983-06-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1986-06-11 | 1986-12-11 | 1987-06-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1990-06-11 | 1990-12-11 | 1991-06-12 | $7700.00 | Window Closed / Lapsed |